Related Experiment Video

Updated: Aug 1, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Effect of incadronate on proliferation of mesenchymal tumor cells with or without activated Ras mutation

H Kawashima1, A Ogose, T Hotta

  • 1Div. of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Journal of Experimental & Clinical Cancer Research : CR
|February 14, 2006
PubMed

Insights

Incadronate, a bisphosphonate, effectively inhibits mesenchymal tumor cell proliferation by blocking oncogenic Ras signaling pathways. This targeted action suppresses tumor growth, offering potential therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Mesenchymal tumors are a diverse group of cancers.
  • Ras signaling pathways are frequently implicated in tumor development.
  • Bisphosphonates are known for their role in treating bone diseases.

Purpose of the Study:

  • To investigate the anti-proliferative effects of bisphosphonates on mesenchymal tumor cell lines.
  • To elucidate the underlying mechanisms of tumor cell proliferation inhibition.
  • To determine the role of Ras signaling in incadronate's efficacy.

Main Methods:

  • Treatment of six mesenchymal tumor cell lines with incadronate and etidronate.
  • Autoradiography to assess drug uptake.
  • Reversal studies using geranylgeranyl pyrophosphate.
  • Comparison of incadronate's effect on oncogenic Ras-transfected cells versus parental cells.

Main Results:

  • Incadronate significantly reduced proliferation in HT-1080 fibrosarcoma cells with mutated Ras.
  • No significant effect was observed in cell lines without Ras mutations.
  • Drug uptake was similar in susceptible and unaffected cells.
  • Anti-proliferative effects were reversed by geranylgeranyl pyrophosphate.
  • Incadronate significantly inhibited proliferation in oncogenic Ras-transfected BALB/3T3 cells (Bhas 42).

Conclusions:

  • Incadronate inhibits the mevalonate pathway, thereby blocking oncogenic Ras signaling.
  • This mechanism underlies incadronate's suppression of oncogenic Ras-activated mesenchymal tumors.
  • Incadronate shows potential as a therapeutic agent for specific mesenchymal tumors driven by Ras activation.

More Related Videos

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...